Blacksmith Medicines

Developed a purpose-built platform focused on the discovery and development of small molecule inhibitors of metal-dependent enzymes.

Launch date

2015

Employees

San Diego California (HQ)

https://blacksmithmedicines.com

https://www.linkedin.com/company/blacksmith-medicines/

Deals in current and previous year:

Forge Therapeutics

Revenues, earnings & profits over time

USD	2021	2022
Revenues	0000	0000
% growth	-	65 %
EBITDA	0000	0000
Profit	0000	0000
EV / revenue	00.0x	00.0x
EV / EBITDA	00.0x	00.0x
R&D budget	0000	0000

Get premium to view all results

Date	Investors	Amount	Round
Jan 2021	investor investor investor investor investor	$0.0	round
Feb 2024*	National Institute for Allergy and Infectious Disease U.S. Department of Health & Human Services	$3.3m	Grant
Total Funding		000k

Forge Therapeutics

ACQUISITION by Blacksmith Medicines Jan 2023